Eagle Genomics said last week that it will work with members of the European Union's Open PHACTS consortium to link the Open PHACTS platform with genomics tools and workflows such as Galaxy as well as to integrate information from reference databases such as Ensembl.
Open PHACTS, short for Open Pharmacological Triple Store, is building a free semantic data integration platform called the Open Pharmacological Space that will allow scientists to explore integrated biological and chemical data.
The OPS platform will attach factual assertions extracted as semantic triples to scientific text. This should make it possible for users to query textual and database information together and identify new drug targets and pharmacological interactions.
Open PHACTS is funded by the European Commission's Innovative Medicine Initiative. The three-year project kicked off in January 2011 with €10 million ($12 million) in IMI funding, €4 million in in-kind funding from the European Federation of Pharmaceutical Industries and Associations, and €2.2 million in funding from other sources.